Locus Cell just moved. Here's exactly what to do next.
Who to reach, what to say, and why now — on Locus Cell, plus every contract, funding round, and exec hire that follows, each with verified, ICP-ranked contacts.
Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.
Get the full Deep Dive on Locus Cell — free.
We'll email your report. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Locus Cell Partners with Cambium Bio for Phase III CDMO Manufacturing of Elate Ocular®.
Contract Type
partnership
Description
Locus Cell has signed a Memorandum of Understanding with Cambium Bio for the contract development and manufacturing of Elate Ocular® related therapies. This partnership marks Locus Cell's first Phase III international CDMO project, enhancing their role in global pharmaceutical manufacturing.